Literature DB >> 23709499

Indomethacin-induced de novo headache in hemicrania continua--fighting fire with fire?

Tim P Jürgens1, Laura H Schulte, Arne May.   

Abstract

INTRODUCTION: The response to indomethacin is an important feature for the diagnosis of hemicrania continua. CASE DESCRIPTION: We report the case of a 34-year-old female patient with a one-year history of strictly unilateral continuous headache with accompanying ipsilateral autonomic symptoms. As diagnostic testing was unremarkable, hemicrania continua was suspected. A dose of 150 mg of indomethacin/day reduced the headache by 80%. Although an increase to 225 mg/day led to a further reduction of headaches, a new onset of moderate to severe pulsating migrainous bilateral headache developed. DISCUSSION: As shown in older studies, indomethacin can induce de novo headaches in a presumably dose-related fashion although the exact mechanism in uncertain. A treatable secondary origin of the indomethacin-induced headaches in patients with hemicrania continua or paroxysmal hemicrania (such as reversible cerebral vasoconstriction syndrome or aseptic meningitis) should be considered and excluded by further diagnostic testing if headaches persist after discontinuation of indomethacin.

Entities:  

Keywords:  Hemicrania continua; headache; indometacin; indomethacin

Mesh:

Substances:

Year:  2013        PMID: 23709499     DOI: 10.1177/0333102413490345

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  6 in total

Review 1.  Hemicrania continua.

Authors:  Robert W Charlson; Matthew S Robbins
Journal:  Curr Neurol Neurosci Rep       Date:  2014-03       Impact factor: 5.081

Review 2.  When indomethacin fails: additional treatment options for "indomethacin responsive headaches".

Authors:  Shuhan Zhu; Brian McGeeney
Journal:  Curr Pain Headache Rep       Date:  2015-03

Review 3.  Hemicrania Continua: a Clinical Perspective on Diagnosis and Management.

Authors:  Amit Mehta; Priyanka Chilakamarri; Adeel Zubair; Deena E Kuruvilla
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-17       Impact factor: 5.081

Review 4.  Indomethacin-responsive headaches.

Authors:  Juliana VanderPluym
Journal:  Curr Neurol Neurosci Rep       Date:  2015       Impact factor: 5.081

Review 5.  Therapeutical approaches to paroxysmal hemicrania, hemicrania continua and short lasting unilateral neuralgiform headache attacks: a critical appraisal.

Authors:  Carlo Baraldi; Lanfranco Pellesi; Simona Guerzoni; Maria Michela Cainazzo; Luigi Alberto Pini
Journal:  J Headache Pain       Date:  2017-07-20       Impact factor: 7.277

6.  Differential actions of indomethacin: clinical relevance in headache.

Authors:  Oliver Summ; Anna P Andreou; Simon Akerman; Philip R Holland; Jan Hoffmann; Peter J Goadsby
Journal:  Pain       Date:  2021-02-01       Impact factor: 7.926

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.